"We have grown through a series of astute investments and earnings accretive acquisitions. We had to do that cautiously, by making difficult decisions because we had little room for error." - SMG chief executive officer Dr Beng Teck Liang.
BT PHOTO: ZHANG XUAN
THESE days Singapore Medical Group (SMG) barely resembles the once ailing entity that it was.
In 2013, the Catalist-listed group faced significant headwinds and losses due to the changing medical landscape in Singapore: declining medical tourism, changing economics of healthcare and...